Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies

Mitchell Evers; Toine Ten Broeke; J.H. Marco Jansen; Maaike Nederend; Firas Hamdan; Karli R. Reiding; Saskia Meyer; Petra Moerer; Iris Brinkman; Thies Rösner; Robert Jan Lebbink; Thomas Valerius; Jeanette H.W. Leusen

doi:10.1080/19420862.2020.1795505

Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies

Mitchell Evers, Toine Ten Broeke, J.H. Marco Jansen, Maaike Nederend, Firas Hamdan, Karli R. Reiding, Saskia Meyer, Petra Moerer, Iris Brinkman, Thies Rösner, Robert Jan Lebbink, Thomas Valerius, Jeanette H.W. Leusen

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Artikelnummer	1795505
Tidskrift	MAbs
Volym	12
Nummer	1
Antal sidor	10
ISSN	1942-0862
DOI	https://doi.org/10.1080/19420862.2020.1795505
Status	Publicerad - 1 jan. 2020
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

317 Farmaci

Åtkomst av dokument

10.1080/19420862.2020.1795505

Novel chimerized IgA CD20 antibodies Improving neutrophil activation against CD20 positive malignanciesSlutlig publicerad version, 2,24 MBLicens: CC BY-NC

Citera det här

@article{5c464ed7de8f49238105e9284ac69884,

title = "Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies",

keywords = "317 Pharmacy, CD20, lgA, antibodies, ADCC, CDC, apoptosis, CD20, IgA, antibodies, ADCC, CDC, apoptosis, B-CELL LYMPHOMA, TROGOCYTOSIS, RITUXIMAB, RECEPTOR, GLYCOSYLATION, OFATUMUMAB, EFFICACY, CANCER",

author = "Mitchell Evers and {Ten Broeke}, Toine and Jansen, {J.H. Marco} and Maaike Nederend and Firas Hamdan and Reiding, {Karli R.} and Saskia Meyer and Petra Moerer and Iris Brinkman and Thies R{\"o}sner and Lebbink, {Robert Jan} and Thomas Valerius and Leusen, {Jeanette H.W.}",

year = "2020",

month = jan,

day = "1",

doi = "10.1080/19420862.2020.1795505",

language = "English",

volume = "12",

journal = "MAbs",

issn = "1942-0862",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - Novel chimerized IgA CD20 antibodies

T2 - Improving neutrophil activation against CD20-positive malignancies

AU - Evers, Mitchell

AU - Ten Broeke, Toine

AU - Jansen, J.H. Marco

AU - Nederend, Maaike

AU - Hamdan, Firas

AU - Reiding, Karli R.

AU - Meyer, Saskia

AU - Moerer, Petra

AU - Brinkman, Iris

AU - Rösner, Thies

AU - Lebbink, Robert Jan

AU - Valerius, Thomas

AU - Leusen, Jeanette H.W.

PY - 2020/1/1

Y1 - 2020/1/1

KW - 317 Pharmacy

KW - CD20

KW - lgA

KW - antibodies

KW - ADCC

KW - CDC

KW - apoptosis

KW - CD20

KW - IgA

KW - antibodies

KW - ADCC

KW - CDC

KW - apoptosis

KW - B-CELL LYMPHOMA

KW - TROGOCYTOSIS

KW - RITUXIMAB

KW - RECEPTOR

KW - GLYCOSYLATION

KW - OFATUMUMAB

KW - EFFICACY

KW - CANCER

U2 - 10.1080/19420862.2020.1795505

DO - 10.1080/19420862.2020.1795505

M3 - Article

VL - 12

JO - MAbs

JF - MAbs

SN - 1942-0862

IS - 1

M1 - 1795505

ER -